AI-generated summary
The authors randomized 62 patients with diabetic foot ulcers to placebo or one of three low-level laser therapy doses at 904 nm, given twice weekly for 20 sessions. They report that laser therapy was associated with better quality of life on several SF-36 domains and a positive association between quality of life and self-care. The study is described as exploratory.
- Participants
- 62
- Who or what was studied
- Patients with diabetic foot ulcers
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The study is described as exploratory, and the abstract does not report a control for multiple comparisons or the size of the effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 10 J/cm2, 8 J/cm2, 4 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Diabetic foot ulcer, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.